{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:48:05Z","timestamp":1793159285709,"version":"4.5.0"},"reference-count":81,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Sickle cell disease (SCD) is a monogenic red blood cell (RBC) disorder with high morbidity and mortality. Here, we report, for the first time, the impact of SCD on the bone marrow (BM) vascular niche, which is critical for hematopoiesis. In SCD mice, we find a disorganized and structurally abnormal BM vascular network of increased numbers of highly tortuous arterioles occupying the majority of the BM cavity, as well as fragmented sinusoidal vessels filled with aggregates of erythroid and myeloid cells. By in vivo imaging, sickle and control RBCs have significantly slow intravascular flow speeds in sickle cell BM but not in control BM. In sickle cell BM, we find increased reactive oxygen species production in expanded erythroblast populations and elevated levels of HIF-1\u03b1. The SCD BM exudate exhibits increased levels of proangiogenic growth factors and soluble vascular cell adhesion molecule-1. Transplantation of SCD mouse BM cells into wild-type mice recapitulates the SCD vascular phenotype. Our data provide a model of SCD BM, in which slow RBC flow and vaso-occlusions further diminish local oxygen availability in the physiologic hypoxic BM cavity. These events trigger a milieu that is conducive to aberrant vessel growth. The distorted neovascular network is completely reversed by a 6-week blood transfusion regimen targeting hemoglobin S to &amp;lt;30%, highlighting the plasticity of the vascular niche. A better insight into the BM microenvironments in SCD might provide opportunities to optimize approaches toward efficient and long-term hematopoietic engraftment in the context of curative therapies.<\/jats:p>","DOI":"10.1182\/blood.2019002227","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T14:53:05Z","timestamp":1580223185000},"page":"2071-2084","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":70,"title":["Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion"],"prefix":"10.1182","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6385-4132","authenticated-orcid":false,"given":"Shin-Young","family":"Park","sequence":"first","affiliation":[{"name":"Transfusion Medicine, Boston Children\u2019s Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Matte","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yookyung","family":"Jung","sequence":"first","affiliation":[{"name":"Center for Molecular Spectroscopy and Dynamics, Institute for Basic Science, Seoul, Republic of Korea;"},{"name":"Center for Systems Biology and Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jina","family":"Ryu","sequence":"first","affiliation":[{"name":"Transfusion Medicine, Boston Children\u2019s Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson Babu","family":"Anand","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Young","family":"Han","sequence":"first","affiliation":[{"name":"Transfusion Medicine, Boston Children\u2019s Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"first","affiliation":[{"name":"Transfusion Medicine, Boston Children\u2019s Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Carbone","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Melisi","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nagasawa","sequence":"first","affiliation":[{"name":"Laboratory of Stem Cell Biology and Developmental Immunology, Graduate School of Frontier Biosciences and Graduate School of Medicine, Osaka University, Osaka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Locascio","sequence":"first","affiliation":[{"name":"Massachusetts Alzheimer\u2019s Disease Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"Lin","sequence":"first","affiliation":[{"name":"Center for Systems Biology and Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4624-0013","authenticated-orcid":false,"given":"Leslie E.","family":"Silberstein","sequence":"first","affiliation":[{"name":"Transfusion Medicine, Boston Children\u2019s Hospital and Harvard Medical School, Boston, MA;"},{"name":"Harvard Stem Cell Institute, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7093-777X","authenticated-orcid":false,"given":"Lucia","family":"De Franceschi","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2020060411212169200_B1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1182\/blood-2013-06-508325","article-title":"A systematic analysis of global anemia burden from 1990 to 2010","volume":"123","author":"Kassebaum","year":"2014","journal-title":"Blood"},{"issue":"9859","key":"2020060411212169200_B2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"issue":"16","key":"2020060411212169200_B3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"2020060411212169200_B4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"Am J Hematol"},{"issue":"22","key":"2020060411212169200_B5","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJM199711273372203","article-title":"Circulating activated endothelial cells in sickle cell anemia","volume":"337","author":"Solovey","year":"1997","journal-title":"N Engl J Med"},{"issue":"7","key":"2020060411212169200_B6","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.V96.7.2451","article-title":"Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion","volume":"96","author":"Belcher","year":"2000","journal-title":"Blood"},{"issue":"5","key":"2020060411212169200_B7","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.052522799","article-title":"Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm","volume":"99","author":"Turhan","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2020060411212169200_B8","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1182\/blood-2012-07-441188","article-title":"Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease","volume":"121","author":"George","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2020060411212169200_B9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nm.1939","article-title":"Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury","volume":"15","author":"Hidalgo","year":"2009","journal-title":"Nat Med"},{"issue":"3","key":"2020060411212169200_B10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1055\/s-0031-1273087","article-title":"Thrombosis and sickle cell disease","volume":"37","author":"De Franceschi","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"2020060411212169200_B11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood-2018-07-865378","article-title":"Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1","volume":"133","author":"Matte","year":"2019","journal-title":"Blood"},{"key":"2020060411212169200_B12","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-203727","article-title":"Moyamoya syndrome in sickle cell anaemia: a cause of recurrent stroke","volume":"2014","author":"Soares","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"1","key":"2020060411212169200_B13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3171\/2014.12.PEDS14522","article-title":"Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease","volume":"16","author":"Griessenauer","year":"2015","journal-title":"J Neurosurg Pediatr"},{"issue":"6","key":"2020060411212169200_B14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2013-12-545186","article-title":"Magnetic resonance imaging\/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial","volume":"124","author":"Helton","year":"2014","journal-title":"Blood"},{"issue":"15","key":"2020060411212169200_B15","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1167\/iovs.16-19513","article-title":"Expression pattern of HIF-1\u03b1 and VEGF supports circumferential application of scatter laser for proliferative sickle retinopathy","volume":"57","author":"Rodrigues","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020060411212169200_B16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mvr.2014.05.009","article-title":"In vitro and in vivo anti-angiogenic effects of hydroxyurea","volume":"94","author":"Lopes","year":"2014","journal-title":"Microvasc Res"},{"issue":"6","key":"2020060411212169200_B17","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3324\/haematol.2014.119727","article-title":"Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea","volume":"100","author":"Lopes","year":"2015","journal-title":"Haematologica"},{"issue":"6","key":"2020060411212169200_B18","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1182\/blood-2014-06-582452","article-title":"Ironing out placenta growth factor","volume":"124","author":"Brittain","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2020060411212169200_B19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bcmd.2014.08.003","article-title":"Increased circulating PEDF and low sICAM-1 are associated with sickle cell retinopathy","volume":"54","author":"Cruz","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"2020060411212169200_B20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2141.2006.06103.x","article-title":"Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease","volume":"134","author":"Duits","year":"2006","journal-title":"Br J Haematol"},{"issue":"5","key":"2020060411212169200_B21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3324\/haematol.2013.099747","article-title":"Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel","volume":"99","author":"Angelucci","year":"2014","journal-title":"Haematologica"},{"issue":"2","key":"2020060411212169200_B22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.seminhematol.2018.04.014","article-title":"Genetic therapies for sickle cell disease","volume":"55","author":"Esrick","year":"2018","journal-title":"Semin Hematol"},{"issue":"7","key":"2020060411212169200_B23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/17474086.2018.1486703","article-title":"Stem cell transplantation in sickle cell disease: therapeutic potential and challenges faced","volume":"11","author":"Leonard","year":"2018","journal-title":"Expert Rev Hematol"},{"issue":"8","key":"2020060411212169200_B24","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.bbmt.2018.03.031","article-title":"Haploidentical peripheral blood stem cell transplantation demonstrates stable engraftment in adults with sickle cell disease","volume":"24","author":"Saraf","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"2020060411212169200_B25","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1182\/blood-2015-04-641969","article-title":"Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease","volume":"126","author":"Dalle Carbonare","year":"2015","journal-title":"Blood"},{"issue":"6960","key":"2020060411212169200_B26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","article-title":"Osteoblastic cells regulate the haematopoietic stem cell niche","volume":"425","author":"Calvi","year":"2003","journal-title":"Nature"},{"issue":"7225","key":"2020060411212169200_B27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature07434","article-title":"Live-animal tracking of individual haematopoietic stem\/progenitor cells in their niche","volume":"457","author":"Lo Celso","year":"2009","journal-title":"Nature"},{"issue":"5","key":"2020060411212169200_B28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/ncb2730","article-title":"Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment [published correction appears in Nat Cell Biol. 2013;15(8):1016]","volume":"15","author":"Nombela-Arrieta","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"7440","key":"2020060411212169200_B29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature11885","article-title":"Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches [published correction appears in Nature. 2014;514(7521):262]","volume":"495","author":"Ding","year":"2013","journal-title":"Nature"},{"issue":"7382","key":"2020060411212169200_B30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature10783","article-title":"Endothelial and perivascular cells maintain haematopoietic stem cells","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"issue":"7473","key":"2020060411212169200_B31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature12612","article-title":"Arteriolar niches maintain haematopoietic stem cell quiescence","volume":"502","author":"Kunisaki","year":"2013","journal-title":"Nature"},{"issue":"3","key":"2020060411212169200_B32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.devcel.2014.03.014","article-title":"Vasculature-associated cells expressing nestin in developing bones encompass early cells in the osteoblast and endothelial lineage","volume":"29","author":"Ono","year":"2014","journal-title":"Dev Cell"},{"issue":"3","key":"2020060411212169200_B33","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4049\/jimmunol.1202639","article-title":"Focal adhesion kinase regulates the localization and retention of pro-B cells in bone marrow microenvironments","volume":"190","author":"Park","year":"2013","journal-title":"J Immunol"},{"issue":"7599","key":"2020060411212169200_B34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature17624","article-title":"Distinct bone marrow blood vessels differentially regulate haematopoiesis [published correction appears in Nature. 2016;538(7624):274.]","volume":"532","author":"Itkin","year":"2016","journal-title":"Nature"},{"issue":"4","key":"2020060411212169200_B35","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood-2006-02-004812","article-title":"Correction of sickle cell disease by homologous recombination in embryonic stem cells","volume":"108","author":"Wu","year":"2006","journal-title":"Blood"},{"issue":"7","key":"2020060411212169200_B36","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1172\/JCI41649","article-title":"CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow","volume":"120","author":"Eash","year":"2010","journal-title":"J Clin Invest"},{"issue":"3","key":"2020060411212169200_B37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cmet.2017.01.001","article-title":"Parathyroid hormone directs bone marrow mesenchymal cell fate","volume":"25","author":"Fan","year":"2017","journal-title":"Cell Metab"},{"issue":"7495","key":"2020060411212169200_B38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature13034","article-title":"Direct measurement of local oxygen concentration in the bone marrow of live animals","volume":"508","author":"Spencer","year":"2014","journal-title":"Nature"},{"issue":"5","key":"2020060411212169200_B39","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00424-016-1797-6","article-title":"The impact of chronic intermittent hypoxia on hematopoiesis and the bone marrow microenvironment","volume":"468","author":"Alvarez-Martins","year":"2016","journal-title":"Pflugers Arch"},{"issue":"8","key":"2020060411212169200_B40","doi-asserted-by":"crossref","first-page":"e0183320","DOI":"10.1371\/journal.pone.0183320","article-title":"Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy","volume":"12","author":"Jee","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"2020060411212169200_B41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/clin.1996.0163","article-title":"Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis","volume":"81","author":"Duits","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"issue":"5","key":"2020060411212169200_B42","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1182\/blood.V94.5.1555","article-title":"Sickle cell acute chest syndrome: pathogenesis and rationale for treatment","volume":"94","author":"Stuart","year":"1999","journal-title":"Blood"},{"issue":"6","key":"2020060411212169200_B43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"issue":"7440","key":"2020060411212169200_B44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature11926","article-title":"CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance","volume":"495","author":"Greenbaum","year":"2013","journal-title":"Nature"},{"issue":"7483","key":"2020060411212169200_B45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"issue":"1","key":"2020060411212169200_B46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/asheducation-2005.1.58","article-title":"An evidence-based approach to the treatment of adults with sickle cell disease","volume":"2005","author":"Lottenberg","year":"2005","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"5","key":"2020060411212169200_B47","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.2012.09060.x","article-title":"Serum ferritin and total units transfused for assessing iron overload in adults with sickle cell disease","volume":"157","author":"Drasar","year":"2012","journal-title":"Br J Haematol"},{"issue":"6","key":"2020060411212169200_B48","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00062752-199911000-00014","article-title":"Transfusion practice for patients with sickle cell disease","volume":"6","author":"Reed","year":"1999","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"2020060411212169200_B49","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"2020060411212169200_B50","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/trf.14767","article-title":"Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis","volume":"58","author":"Vianello","year":"2018","journal-title":"Transfusion"},{"issue":"1-2","key":"2020060411212169200_B51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0006-8993(97)01407-8","article-title":"Xanthine oxidase-derived superoxide causes reoxygenation injury of ischemic cerebral endothelial cells","volume":"786","author":"Beetsch","year":"1998","journal-title":"Brain Res"},{"issue":"2","key":"2020060411212169200_B52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0167-4889(95)00111-5","article-title":"Deleterious effects of xanthine oxidase on rat liver endothelial cells after ischemia\/reperfusion","volume":"1269","author":"Hamer","year":"1995","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2020060411212169200_B53","doi-asserted-by":"crossref","first-page":"H2715","DOI":"10.1152\/ajpheart.00986.2004","article-title":"Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice","volume":"288","author":"Belcher","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"2020060411212169200_B54","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J Clin Invest"},{"issue":"5","key":"2020060411212169200_B55","doi-asserted-by":"crossref","first-page":"e45054","DOI":"10.15252\/embr.201745054","article-title":"EphrinB2\/EphB4 signaling regulates non-sprouting angiogenesis by VEGF","volume":"19","author":"Groppa","year":"2018","journal-title":"EMBO Rep"},{"issue":"7","key":"2020060411212169200_B56","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nm0710-752","article-title":"VEGF and ephrin-B2: a bloody duo","volume":"16","author":"Germain","year":"2010","journal-title":"Nat Med"},{"issue":"3","key":"2020060411212169200_B57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10456-010-9183-z","article-title":"The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis","volume":"13","author":"Martiny-Baron","year":"2010","journal-title":"Angiogenesis"},{"issue":"6","key":"2020060411212169200_B58","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2013-11-539718","article-title":"Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Kr\u00fcppel-like factor","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2020060411212169200_B59","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat Med"},{"key":"2020060411212169200_B60","doi-asserted-by":"crossref","first-page":"549412","DOI":"10.1155\/2015\/549412","article-title":"Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: applications and therapies","volume":"2015","author":"Zimna","year":"2015","journal-title":"BioMed Res Int"},{"issue":"2","key":"2020060411212169200_B61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","article-title":"Pericytes: developmental, physiological, and pathological perspectives, problems, and promises","volume":"21","author":"Armulik","year":"2011","journal-title":"Dev Cell"},{"issue":"1","key":"2020060411212169200_B62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","article-title":"Angiopoietins in angiogenesis","volume":"328","author":"Fagiani","year":"2013","journal-title":"Cancer Lett"},{"issue":"7","key":"2020060411212169200_B63","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molmed.2011.01.015","article-title":"VEGF and angiopoietin signaling in tumor angiogenesis and metastasis","volume":"17","author":"Saharinen","year":"2011","journal-title":"Trends Mol Med"},{"issue":"38","key":"2020060411212169200_B64","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1038\/sj.onc.1203035","article-title":"New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF","volume":"18","author":"Holash","year":"1999","journal-title":"Oncogene"},{"issue":"5422","key":"2020060411212169200_B65","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","article-title":"Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF","volume":"284","author":"Holash","year":"1999","journal-title":"Science"},{"issue":"11","key":"2020060411212169200_B66","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1172\/JCI0217326","article-title":"Getting Tie(2)d up in angiogenesis","volume":"110","author":"Ramsauer","year":"2002","journal-title":"J Clin Invest"},{"key":"2020060411212169200_B67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bcmd.2016.10.009","article-title":"Aberrant bone marrow vascularization patterns in untreated patients with Gaucher disease type 1","volume":"68","author":"Klimkowska","year":"2018","journal-title":"Blood Cells Mol Dis"},{"issue":"9442","key":"2020060411212169200_B68","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"Stuart","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"2020060411212169200_B69","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1074-7613(03)00201-2","article-title":"Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny","volume":"19","author":"Ara","year":"2003","journal-title":"Immunity"},{"issue":"3","key":"2020060411212169200_B70","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/jcb.21043","article-title":"Cytokines and hematopoietic stem cell mobilization","volume":"99","author":"Nervi","year":"2006","journal-title":"J Cell Biochem"},{"issue":"1","key":"2020060411212169200_B71","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1038\/ncomms6914","article-title":"Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells\/progenitors through endothelial AT2R and cytoskeletal dysregulation","volume":"6","author":"Chang","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"2020060411212169200_B72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1084\/jem.20031104","article-title":"Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression","volume":"199","author":"Ueda","year":"2004","journal-title":"J Exp Med"},{"issue":"9","key":"2020060411212169200_B73","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1182\/blood-2004-01-0272","article-title":"G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow","volume":"106","author":"Semerad","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2020060411212169200_B74","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1172\/JCI15956","article-title":"Spontaneous circulation of myeloid-lymphoid-initiating cells and SCID-repopulating cells in sickle cell crisis","volume":"111","author":"Lamming","year":"2003","journal-title":"J Clin Invest"},{"issue":"4","key":"2020060411212169200_B75","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood.V94.4.1451","article-title":"Altered hematopoiesis in murine sickle cell disease","volume":"94","author":"Blouin","year":"1999","journal-title":"Blood"},{"issue":"4","key":"2020060411212169200_B76","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1148\/radiographics.21.4.g01jl23971","article-title":"Sickle cell anemia","volume":"21","author":"Lonergan","year":"2001","journal-title":"Radiographics"},{"issue":"7","key":"2020060411212169200_B77","first-page":"896","article-title":"Natural history and distribution of bone and bone marrow infarction in sickle hemoglobinopathies","volume":"43","author":"Kim","year":"2002","journal-title":"J Nucl Med"},{"key":"2020060411212169200_B78","first-page":"168","volume-title":"Blood","author":"Baronciani","year":"2018"},{"issue":"11","key":"2020060411212169200_B79","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.15252\/emmm.201505889","article-title":"Targeting key angiogenic pathways with a bispecific crossMAb optimized for neovascular eye diseases","volume":"8","author":"Regula","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"1-2","key":"2020060411212169200_B80","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10827-009-0159-1","article-title":"Rapid determination of particle velocity from space-time images using the Radon transform","volume":"29","author":"Drew","year":"2010","journal-title":"J Comput Neurosci"},{"issue":"7","key":"2020060411212169200_B81","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/jcbfm.2011.196","article-title":"Two-photon microscopy as a tool to study blood flow and neurovascular coupling in the rodent brain [published correction appears in J Cereb Blood Flow Metab. 2013;33(2):319]","volume":"32","author":"Shih","year":"2012","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/23\/2071\/1743343\/bloodbld2019002227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/23\/2071\/1743343\/bloodbld2019002227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:22:37Z","timestamp":1591312957000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/135\/23\/2071\/440961\/Pathologic-angiogenesis-in-the-bone-marrow-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":81,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,6,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019002227","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,4]]}}}